Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low grade tumor with neuroendocrine differentiation that arises from the appendix. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.
Biomarker and diagnostic research for appendix neuroendocrine tumor G1 has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions and gene therapy. Research is primarily sponsored by academic and government institutions.
14 publications have been identified in PubMed for appendix neuroendocrine tumor G1. Research spans Case Report / Case Series (50%), Epidemiology / Natural History (21%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 50% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 2:55 AM UTC
Disease patterns and progression |
3 |
21% |
Research summaries | 2 | 14% |
Testing and diagnosis research | 1 | 7% |
Clinical study results | 1 | 7% |
Benguechea B (2026). [PMID: 42266551](https://pubmed.ncbi.nlm.nih.gov/42266551/). *Cureus*. [Case Report / Case Series]
Aomatsu N (2026). [PMID: 41748520](https://pubmed.ncbi.nlm.nih.gov/41748520/). *Gan to kagaku ryoho. Cancer & chemotherapy*. [Case Report / Case Series]
Tian Y (2026). [PMID: 42147241](https://pubmed.ncbi.nlm.nih.gov/42147241/). *Front Oncol*. [Case Report / Case Series]
Belev B (2026). [PMID: 41812599](https://pubmed.ncbi.nlm.nih.gov/41812599/). *Surgical oncology*. [Epidemiology / Natural History]
Ergenç M (2026). [PMID: 41998800](https://pubmed.ncbi.nlm.nih.gov/41998800/). *Cancer Control*. [Diagnostic / Biomarker]
Kuhlen M (2025). [PMID: 41647110](https://pubmed.ncbi.nlm.nih.gov/41647110/). *Frontiers in endocrinology*. [Review / Meta-Analysis]
Kim Y (2025). [PMID: 39740871](https://pubmed.ncbi.nlm.nih.gov/39740871/). *In vivo (Athens, Greece)*. [Review / Meta-Analysis]
Doucet L (2025). [PMID: 41288685](https://pubmed.ncbi.nlm.nih.gov/41288685/). *Virchows Archiv : an international journal of pathology*. [Case Report / Case Series]
Karges K (2025). [PMID: 40996947](https://pubmed.ncbi.nlm.nih.gov/40996947/). *Neuroendocrinology*. [Epidemiology / Natural History]
Cavalcoli F (2025). [PMID: 41301817](https://pubmed.ncbi.nlm.nih.gov/41301817/). *Biomedicines*. [Epidemiology / Natural History]